Stay updated on Nivolumab for High-Risk Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for High-Risk Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for High-Risk Prostate Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.4, replacing the previous v3.6.3. This is a minor version update that does not change the study content or user-facing information.
    Difference
    0.1%
    Check dated 2026-07-25T09:55:40.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The study details page now shows revision v3.6.3, indicating a small maintenance update to the page template rather than changes to the study information.
    Difference
    0.1%
    Check dated 2026-07-03T22:58:48.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.0 to v3.6.2 on the page, indicating a newer revision of the ClinicalTrials.gov entry. This is a routine maintenance update that does not change the study details or user-facing content.
    Difference
    0.3%
    Check dated 2026-06-26T19:51:36.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    Recruitment status updated to 'No longer looking for participants' and new help sections added (How to Read a Study Record, Common Questions, How to Join a Study). A header label related to Intervention/Treatment was adjusted and the revision footer updated to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T12:25:26.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    New related topics such as Prostate cancer and MedlinePlus Genetics were added to the page, and the site revision was updated from v3.5.4 to v3.5.5. These changes update metadata and navigation references without altering the study content or results shown on the page.
    Difference
    0.2%
    Check dated 2026-06-05T08:25:48.000Z thumbnail image
  9. Check
    83 days ago
    Change Detected
    Summary
    The study record now includes a Results Posted entry and updates to several primary and secondary outcomes (e.g., disease control rate at 12 weeks, PSA dynamics, radiographic progression, and treatment-related adverse events) along with related documents. Several older PSA-related outcomes were removed.
    Difference
    3%
    Check dated 2026-05-14T21:52:20.000Z thumbnail image

Stay in the know with updates to Nivolumab for High-Risk Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for High-Risk Prostate Cancer Clinical Trial page.